Research and Markets has announced the addition of the "Anti-Infectives Market Analysis & Trends - Product (Antibacterials, Antifungals and Antivirals) - Forecast to 2025" report to their offering.
The Global Anti-Infectives Market is poised to grow at a CAGR of around 6.3% over the next decade to reach approximately $190.28 billion by 2025. Some of the prominent trends that the market is witnessing include availability of new and effective agents in primary care clinics, rapid emergence of new infectious diseases and recent R&D programs by top players in pharmaceutical and biotechnology.
Based on product type the market is categorized into antibacterials, antifungals and antivirals. Antibacterials segment is further segmented into antibacterials macrolides, carbopenems, cephalosporins, miscellaneous, penicillins, quinolones, sulfonamides and tetracyclines. Antifungals are further segregated into allylamines, azoles polyene macrolides and other antifungals. Antivirals segment is further classified into DNA polymerase inhibitors, nucleoside analogs, protease inhibitors and transcriptase inhibitors.
1 Market Outline
2 Executive Summary
3 Market Overview
4 Anti-Infectives Market, By Product Type
5 Anti-Infectives Market, By Geography
6 Leading Companies
For more information about this report visit http://www.researchandmarkets.com/research/wswhbw/antiinfectives
View source version on businesswire.com: http://www.businesswire.com/news/home/20161122005623/en/Business Wire
Last updated on: 22/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.